EMEA-001539-PIP01-13-M06 - paediatric investigation plan

sodium zirconium cyclosilicate
PIPHuman

Key facts

Invented name
  • Lokelma
  • Lokelma
Active Substance
sodium zirconium cyclosilicate
Therapeutic area
Metabolism and nutrition disorders
Decision number
P/0077/2024
PIP number
EMEA-001539-PIP01-13-M06
Pharmaceutical form(s)
Powder for oral suspension
Condition(s) / indication(s)
Treatment of hyperkalaemia
Route(s) of administration
Oral use
Contact for public enquiries

AstraZeneca AB

Email: paediatrics@astrazeneca.com 
Tel. +46 855324400 
 

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page